Adverse effects of clinical trial data transparency – should we worry?
New legislation forces drug developers to disclose most of their clinical trials data when applying for approval of a new drug. Many will probably think that this is a good idea. However, too much transparency in drug development ...
Jul 13, 2015
0
29